Skip to main content

Eugeni Bruguera Cortada

Institutions of which they are part

Senior researcher
Psychiatry, Mental Health and Addictions
Vall Hebron Institut de Recerca

Eugeni Bruguera Cortada

Institutions of which they are part

Senior researcher
Psychiatry, Mental Health and Addictions
Vall Hebron Institut de Recerca

Projects

An effectiveness and safety study of varenicline for smoking cessation in hospitalized patients with psychiatric disorders

IP: Eugeni Bruguera Cortada
Collaborators: -
Funding agency: Pfizer Inc
Funding: 90196.52
Reference: VARENICLINE_WI231379-PFIZER2017
Duration: 29/01/2018 - 01/04/2020

Related news

The study, conducted with more than 1,400 people with addictive disorders, delves into the biological mechanisms that connect mental health, life trajectory and educational opportunities.

The European project DISCOvERIE, led by Vall d’Hebron, paves the way for more personalized diagnoses and new treatment strategies to improve patients’ quality of life.

The meeting takes place within the framework of Healing Arts Barcelona, with the aim of exploring and debating how participation in artistic activities can help improve physical and mental health.

Related professionals

Hanaa Boudoukhan Benriyyan

Hanaa Boudoukhan Benriyyan

Predoctoral researcher
Psychiatry, Mental Health and Addictions
Read more
Xavier Cañas Perea

Xavier Cañas Perea

Director/a d'Àrea
Clinical Research Development Directorate
Read more
Júlia Comulada Ferrer

Júlia Comulada Ferrer

Research technician
Clinical Neuroimmunology
Read more
Raul Juntas Morales

Raul Juntas Morales

Head of group
Peripheral Nervous System
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.